Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 217

The DOI matches its Crossref record.

Minimally Invasive Esophagectomy: Results of a Prospective Phase II Multicenter Trial—the Eastern Cooperative Oncology Group (E2202) Study

Open access
Luketich, James D., Pennathur, Arjun, Franchetti, Yoko, Catalano, Paul J., Swanson, Scott, Sugarbaker, David J., De Hoyos, Alberto, Maddaus, Michael A., Nguyen, Ninh T., Benson, Al B., Fernando, Hiran C. · 2015 · Annals of Surgery

Abstract

In Brief Objective: The primary aim of this trial was to assess the feasibility of minimally invasive esophagectomy (MIE) in a multi-institutional setting. Background: Esophagectomy is an important, potentially curative treatment for localized esophageal cancer, but is a complex operation. MIE may decrease the morbidity and mortality of resection, and single-institution studies have demonstrated successful outcomes with MIE. Methods: We conducted a multicenter, phase II, prospective, cooperative group study (coordinated by the Eastern Cooperative Oncology Group) to evaluate the feasibility of MIE. Patients with biopsy-proven high-grade dysplasia or esophageal cancer were enrolled at 17 credentialed sites. Protocol surgery consisted of either 3-stage MIE or Ivor Lewis MIE. The primary end point was 30-day mortality. Secondary end points included adverse events, duration of hospital-stay, and 3-year outcomes. Results: Protocol surgery was completed in 95 of the 104 patients eligible for the primary analysis (91.3%). The 30-day mortality in eligible patients who underwent MIE was 2.1%; perioperative mortality in all registered patients eligible for primary analysis was 2.9%. Median intensive care unit and hospital stay were 2 and 9 days, respectively. Grade 3 or higher adverse events included anastomotic leak (8.6%), acute respiratory distress syndrome (5.7%), pneumonitis (3.8%), and atrial fibrillation (2.9%). At a median follow-up of 35.8 months, the estimated 3-year overall survival was 58.4% (95% confidence interval: 47.7%–67.6%). Locoregional recurrence occurred in only 7 patients (6.7%). Conclusions: This prospective multicenter study demonstrated that MIE is feasible and safe with low perioperative morbidity and mortality and good oncological results. This approach can be adopted by other centers with appropriate expertise in open esophagectomy and minimally invasive surgery. This is the first prospective phase II multicenter study of minimally invasive esophagectomy (MIE) for esophageal cancer undertaken, with the participation of a total of 17 institutions. The study showed that MIE can be performed safely in a multi-institutional setting, with acceptable perioperative morbidity and mortality. In addition, this report provides long-term follow-up demonstrating good oncological outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/sla.0000000000000993

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 217

Metadata

Authors
Luketich, J. D., Pennathur, A., Franchetti, Y., Catalano, P. J., Swanson, S., Sugarbaker, D. J., De Hoyos, A., Maddaus, M. A., Nguyen, N. T., Benson, A. B., & Fernando, H. C.
Venue
Annals of Surgery
Published
2015-04
Volume
261
Issue
4
Pages
702-707
ISSN
0003-4932 (ISSN-L)
OpenAlex
W2056627767
Cited by
217
References
0
FWCI
25.15
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Minimally Invasive Esophagectomy: Results of a Prospective Phase II Multicenter Trial—the Eastern Cooperative Oncology Group (E2202) Study. https://app.cochat.ai/papers/10.1097/sla.0000000000000993
The paper
Luketich, J. D., Pennathur, A., Franchetti, Y., Catalano, P. J., Swanson, S., Sugarbaker, D. J., De Hoyos, A., Maddaus, M. A., Nguyen, N. T., Benson, A. B., & Fernando, H. C. (2015). Minimally Invasive Esophagectomy: Results of a Prospective Phase II Multicenter Trial—the Eastern Cooperative Oncology Group (E2202) Study. Annals of Surgery. https://doi.org/10.1097/sla.0000000000000993

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.